CSN Login
Members Online: 4

You are here

CSN Home › Discussion boards › Cancer specific › Colorectal Cancer

Phase I study on patients with oxi refractory/intolerant KRAS mutant CRC

coloCan
Posts: 1956
Joined: Oct 2009
May 19, 2010 - 2:06 pm

announced this date by Calgary, Canada-based Oncolytics Biotech, which will consist of FOLFIRI (Leucovorin,5FU and Irinotecan)with this new thing called Reolysin (REO). For more info see www.prnewsire.com or
rttnews.com

Hope this helps someone
Subscribe to Comments for "Phase I study on patients with oxi refractory/intolerant KRAS mutant CRC"

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2019 © Cancer Survivors Network